(REN) Relx - Overview
Sector: Industrials | Industry: Specialty Business Services | Exchange: AS (Netherlands) | Market Cap: 50.168m EUR | Total Return: -38.7% in 12m
Avg Turnover: 31.3M
Warnings
Below Avwap Earnings
Tailwinds
No distinct edge detected
RELX PLC is a global provider of information-based analytics and decision tools across four primary divisions: Risk, Scientific, Technical & Medical (STM), Legal, and Exhibitions. The company utilizes proprietary algorithms and expansive data sets to help professional clients evaluate risks, access scientific research, and manage legal workflows. Headquartered in London, the firm transitioned from a traditional publishing model to a data-driven technology provider, formally rebranding from Reed Elsevier in 2015.
The business operates within the professional services sector, characterized by high barriers to entry due to the specialized nature of its intellectual property. Its revenue model relies heavily on recurring subscriptions, which provide stability compared to cyclical advertising-based media. In the STM segment, the company manages a vast repository of peer-reviewed journals, serving as a critical infrastructure for the global academic and medical research communities.
For a deeper dive into these business segments and historical performance, consider reviewing the detailed metrics on ValueRay. The Exhibitions segment further complements this data focus by integrating digital lead-generation tools into its international trade show operations.
- AI-driven risk analytics demand fuels double-digit revenue growth in Risk segment
- Academic journal subscription renewals provide stable high-margin recurring cash flows
- Legal segment margin expansion accelerates through integrated generative AI research tools
- Global exhibition volumes recover to pre-pandemic levels driving cyclical revenue upside
- Shift toward open access publishing models pressures traditional scientific segment margins
| Net Income: 4.00b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.34 > 0.02 and ΔFCF/TA 19.43 > 1.0 |
| NWC/Revenue: -15.95% < 20% (prev -19.03%; Δ 3.08% < -1%) |
| CFO/TA 0.37 > 3% & CFO 5.48b > Net Income 4.00b |
| Net Debt (7.30b) to EBITDA (7.04b): 1.04 < 3 |
| Current Ratio: 0.49 > 1.5 & < 3 |
| Outstanding Shares: last quarter (1.83b) vs 12m ago -3.30% < -2% |
| Gross Margin: 65.00% > 18% (prev 0.65%; Δ 6.44k% > 0.5%) |
| Asset Turnover: 128.2% > 50% (prev 92.14%; Δ 36.06% > 0%) |
| Interest Coverage Ratio: 10.21 > 6 (EBITDA TTM 7.04b / Interest Expense TTM 570.1m) |
| DSRI: 0.88 (Receivables 2.47b/2.03b, Revenue 19.0b/13.7b) |
| GMI: 0.99 (GM 65.00% / 64.66%) |
| AQI: 0.99 (AQ_t 0.79 / AQ_t-1 0.79) |
| SGI: 1.38 (Revenue 19.0b / 13.7b) |
| TATA: -0.10 (NI 4.00b - CFO 5.48b) / TA 14.8b) |
| Beneish M = -2.96 (Cap -4..+1) = A |
As of May 30, 2026, the stock is trading at EUR 28.40 with a total of 1,741,757 shares traded.
Over the past week, the price has changed by +0.07%,
over one month by -5.52%,
over three months by -1.67% and
over the past year by -38.66%.
Relx has no consensus analysts rating.
Market Cap GBP = 43.4b (50.2b EUR * 0.866 EUR.GBP)
P/E Trailing = 22.0
P/E Forward = 17.1527
P/S = 5.2313
P/B = 18.34
P/EG = 1.3204
Revenue TTM = 19.0b GBP
EBIT TTM = 5.82b GBP
EBITDA TTM = 7.04b GBP
Long Term Debt = 5.63b GBP (from longTermDebt, last quarter)
Short Term Debt = 1.57b GBP (from shortTermDebt, last quarter)
Debt = 7.44b GBP (from shortLongTermDebtTotal, last quarter) + Leases 97.0m
Net Debt = 7.30b GBP (calculated: Debt 7.44b - CCE 131.1m)
Enterprise Value = 50.8b GBP (43.4b + Debt 7.44b - CCE 131.1m)
Interest Coverage Ratio = 10.21 (Ebit TTM 5.82b / Interest Expense TTM 570.1m)
EV/FCF = 10.21x (Enterprise Value 50.8b / FCF TTM 4.97b)
FCF Yield = 9.80% (FCF TTM 4.97b / Enterprise Value 50.8b)
FCF Margin = 26.13% (FCF TTM 4.97b / Revenue TTM 19.0b)
Net Margin = 21.02% (Net Income TTM 4.00b / Revenue TTM 19.0b)
Gross Margin = 65.00% ((Revenue TTM 19.0b - Cost of Revenue TTM 6.66b) / Revenue TTM)
Gross Margin QoQ = 63.75% (prev 66.25%)
Tobins Q-Ratio = 3.44 (Enterprise Value 50.8b / Total Assets 14.8b)
Interest Expense / Debt = 7.67% (Interest Expense 570.1m / Debt 7.44b)
Taxrate = 25.09% (368.2m / 1.47b)
NOPAT = 4.36b (EBIT 5.82b * (1 - 25.09%))
Current Ratio = 0.49 (Total Current Assets 2.96b / Total Current Liabilities 6.00b)
Debt / Equity = 3.14 (Debt 7.44b / totalStockholderEquity, last quarter 2.37b)
Debt / EBITDA = 1.04 (Net Debt 7.30b / EBITDA 7.04b)
Debt / FCF = 1.47 (Net Debt 7.30b / FCF TTM 4.97b)
Total Stockholder Equity = 2.81b (last 4 quarters mean from totalStockholderEquity)
RoA = 26.95% (Net Income 4.00b / Total Assets 14.8b)
RoE = 142.3% (Net Income TTM 4.00b / Total Stockholder Equity 2.81b)
RoCE = 68.99% (EBIT 5.82b / Capital Employed (Equity 2.81b + L.T.Debt 5.63b))
RoIC = 42.17% (NOPAT 4.36b / Invested Capital 10.3b)
WACC = 6.87% (E(43.4b)/V(50.9b) * Re(7.06%) + D(7.44b)/V(50.9b) * Rd(7.67%) * (1-Tc(0.25)))
Discount Rate = 7.06% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -82.22 | Cagr: -2.44%
[DCF] Terminal Value 77.97% ; FCFF base≈3.83b ; Y1≈4.39b ; Y5≈6.47b
[DCF] Fair Price = 50.91 (EV 97.3b - Net Debt 7.30b = Equity 90.0b / Shares 1.77b; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: N/A | EPS CAGR: N/A | SUE: 0.0 | # QB: 0
Revenue Correlation: 99.27 | Revenue CAGR: 2.35% | SUE: N/A | # QB: 0
EPS current Year (2026-12-31): EPS=1.66 | Chg30d=-0.26% | Revisions=+0% | GrowthEPS=+12.7% | GrowthRev=+5.8%
EPS next Year (2027-12-31): EPS=1.87 | Chg30d=-2.11% | Revisions=+20% | GrowthEPS=+12.6% | GrowthRev=+6.3%
[Analyst] Revisions Ratio: +20%